Search - tctmd.com

Displaying 61 - 76 of 76

Sort: Relevancy | Date

News Industry News

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

May 07, 2015

News Conference News AHA 2014

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

November 18, 2014

Presentation TCT 2014

BVS in ACS

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Mohammad Al-Mutairi

September 16, 2014

Presentation TCT 2014

BVS Gulf Experience and a Complex BVS Implant

Presenter: George D. Dangas, Ziyad M. Hijazi, Roxana Mehran, Abdullah Shehab, Arif Al Nooryani

September 16, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

Caitlin E. Cox

September 03, 2014

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

Presentation TCT Russia 2013

Stent Selection in Contemporary PCI: Translating Evidence into Everyday Practice

Presenter: Roxana Mehran

June 09, 2013

Presentation PCI Outcomes 2013

Approach to the Patient with DES Restenosis

Presenter: Roxana Mehran

March 07, 2013

Presentation TCT 2013

Outcomes of high-risk patients undergoing percutaneous coronary interventions in the ambulatory versus in-hospital setting

Presenter: Mark Kahn, Annapoorna Kini, Ziad Sergie, Roxana Mehran, Samin Sharma, Michael Kim

January 31, 2013

Presentation TCT 2013

Impact of Moderate and Severe Coronary Calcification on 1-Year Outcomes after PCI with DES: A Pooled Analysis of 11,651 Patients from 14 Randomized Trials

Presenter: Philippe Genereux, Ajay Kirtane, Sorin Brener, Akiko Maehara, Tullio Palmerini, Martin Fahy, Roxana Mehran, Gregg Stone

January 31, 2013

Presentation TCT 2012

Proposals for New Short-Term DAPT Use Trials After DES

Presenter: Roxana Mehran

October 25, 2012

Presentation TCT 2012

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Presenter: Roxana Mehran

October 23, 2012

News Daily News

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

Yael L. Maxwell

February 15, 2012

News Daily News

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Leah Lawrence

September 29, 2011

News Conference News

Therapies Take on In-Stent Restenosis with Mixed Results

Caitlin E. Cox

April 15, 2011

CME

Advertisement

Antiplatelet Drug Ticagrelor More Effective Than Clopidogrel for Ad Hoc PCI Patients

Biodegradable-Polymer DES Perform Well But Appear No Safer than Their Durable-Polymer Counterparts

BVS in ACS

BVS Gulf Experience and a Complex BVS Implant

PROTECT: ZES Sustain Lead Over SES at 5 Years

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Stent Selection in Contemporary PCI: Translating Evidence into Everyday Practice

Approach to the Patient with DES Restenosis

Outcomes of high-risk patients undergoing percutaneous coronary interventions in the ambulatory versus in-hospital setting

Impact of Moderate and Severe Coronary Calcification on 1-Year Outcomes after PCI with DES: A Pooled Analysis of 11,651 Patients from 14 Randomized Trials

Proposals for New Short-Term DAPT Use Trials After DES

In-Stent Restenosis: Mechanisms, Predictors, and Treatment

Complications of In-Stent Restenosis High, Traditional Risk Factors Absent

HORIZONS-AMI: CKD Patients Fare Poorly Regardless of Stent Type, Antithrombotic Regimen

Therapies Take on In-Stent Restenosis with Mixed Results

Latest Data on Left Main Stenting and its Implications

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content